ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,297.10
-0.21%
US Tech 100
18,092.00
0.07%
다우존스 지수
39,869.38
-0.10%
Bitcoin
66,418.12
1.81%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Mereo BioPharma Group PLC (MREO)

  7. Mereo BioPharma Group PLC (MREO) 뉴스

MREO

Mereo BioPharma (MREO)

Mereo BioPharma Group PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MREO
일자시간출처헤드라인심볼기업
2024/05/1605:49Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MREOMereo BioPharma Group PLC
2024/05/1605:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MREOMereo BioPharma Group PLC
2024/05/1605:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
2024/05/1605:01GlobeNewswire Inc.Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
2024/04/0320:30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:MREOMereo BioPharma Group PLC
2024/03/2805:01GlobeNewswire Inc.Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
2024/03/0521:30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma ConferenceNASDAQ:MREOMereo BioPharma Group PLC
2024/02/1006:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/02/1006:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/02/1006:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/02/1006:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/02/0706:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
2024/01/2706:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/2706:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/2406:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0821:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0821:00GlobeNewswire Inc.Mereo BioPharma Provides Update on Pipeline Progress and Corporate DevelopmentsNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2024/01/0306:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
2023/12/1906:16Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
2023/12/1906:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
2023/11/3006:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
2023/11/1621:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
2023/10/2405:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
2023/10/2405:01GlobeNewswire Inc.Mereo BioPharma Reports on Recent Program Developments and Provides Financial UpdateNASDAQ:MREOMereo BioPharma Group PLC
 검색 관련기사 보기:NASDAQ:MREO

최근 히스토리

BOV
PETRT294
PETRT294 Ex:26,7
BIT
F18684
Vontobel Financial Produ...
BIT
F16128
Vontobel Financial Produ...
KOSPI
000850
화천기공
NASDAQ
LCAHW
Landcadia Holdings IV
BFNX
KSMUST
COIN
CTSIETH
Cartesi Token
BOV
BBDCF233
BBDCF233 Ex:23,42
COIN
PRAETH
ASE
BLEKEDROS
Mple Kerdos REIC
NYSE
SWBK
Switchback II
NASDAQ
MPWR
Monolithic Power Systems
OKEX
USDTEUR
Tether USD
COIN
CRYUSD
USOTC
ETCIA
Electronic TeleCommunica... (CE)
BIT
X45704
Natixis Structured Issua...
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유